CBX8 Promotes Epithelial-mesenchymal Transition, Migration, and Invasion of Lung Cancer Through Wnt/β-catenin Signaling Pathway

Overview

Journal Curr Protein Pept Sci

Publisher Bentham Science Publishers

Specialty Biochemistry

Date 2024 Jan 24

PMID 38265409

Authors

Xiaoping Cai

Yuankai Lv

Jiongwei Pan

Zhuo Cao

Junzhi Zhang

Yuling Li

Hao Zheng

Affiliations

Soon will be listed here.

Abstract

Background: Lung cancer (LC) is primarily responsible for cancer-related deaths worldwide. Epithelial-mesenchymal transition (EMT) is a process in which epithelial cells acquire mesenchymal features and is associated with the development of tumors. CBX8, a member of the PcG protein family, plays a critical role in various cancers, containing LC. However, specific regulatory mechanisms of CBX8 in LC progression are not fully understood. This study aimed to investigate the regulatory role of CBX8 in LC progression.

Methods: Bioinformatics was used to analyze the relationship between CBX8 level and tumor and the enrichment pathway of CBX8 enrichment. qRT-PCR was used to detect the differential expression of CBX8 in LC cells and normal lung epithelial cells. The effects of knockdown or overexpression of CBX8 on the proliferation, migration and invasion of LC cells were evaluated by CCK- -8 assay and Transwell assay, and the levels of proteins associated with the EMT pathway and Wnt/ β-catenin signaling pathway were detected by western blot.

Results: Bioinformatics analysis revealed that CBX8 was highly expressed in LC and enriched on the Wnt/β-catenin signaling pathway. The expression level of CBX8 was significantly elevated in LC cells. Knockdown of CBX8 significantly inhibited cell proliferation, migration and invasion, and decreased the expression levels of EMT-related proteins and Wnt/β-catenin pathway-related proteins. Conversely, overexpression of CBX8 promoted cell proliferation, migration and invasion, and increased the expression levels of EMT-related proteins and Wnt/β-catenin pathway-related proteins. The Wnt inhibitor IWP-4 alleviated the effects produced by overexpression of CBX8.

Conclusion: Collectively, these data demonstrated that CBX8 induced EMT through Wnt/β-- catenin signaling, driving migration and invasion of LC cells.

Citing Articles

Integrated bioinformatics investigation and experimental validation reveals the clinical and biological significance of chromobox family in breast cancer.

Ge X, Lei S, Wang P, Wang W, Deng M, Niu G Sci Rep. 2025; 15(1):6442.

PMID: 39987187 PMC: 11846889. DOI: 10.1038/s41598-025-90771-0.

References

Salem H . Cancer status in the Occupied Palestinian Territories: types; incidence; mortality; sex, age, and geography distribution; and possible causes. J Cancer Res Clin Oncol. 2022; 149(8):5139-5163. PMC: 9645346. DOI: 10.1007/s00432-022-04430-2. View

Nigro O, Tuzi A, Coppola A, Tartaro T, Chini C, Pinotti G . Combination of radiation therapy for brain metastasis and anti-PD-1/PD-L1 treatment in non-small cell lung cancer: two cases and review of the literature. Anticancer Drugs. 2021; 32(4):460-464. DOI: 10.1097/CAD.0000000000000996. View

Liu B . [Current Treatment Status and Prospect of Surgery and Thermal Ablation for  Pulmonary Oligometastases in Non-small Cell Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2023; 26(3):238-244. PMC: 10106791. DOI: 10.3779/j.issn.1009-3419.2023.106.06. View

Vinod S, Hau E . Radiotherapy treatment for lung cancer: Current status and future directions. Respirology. 2020; 25 Suppl 2:61-71. DOI: 10.1111/resp.13870. View

Zhao Y, Yu L, Wang L, Wu Y, Chen H, Wang Q . Current status of and progress in the treatment of malignant pleural effusion of lung cancer. Front Oncol. 2023; 12:961440. PMC: 9933866. DOI: 10.3389/fonc.2022.961440. View

Carter B, Halpenny D, Ginsberg M, Papadimitrakopoulou V, de Groot P . Immunotherapy in Non-Small Cell Lung Cancer Treatment: Current Status and the Role of Imaging. J Thorac Imaging. 2017; 32(5):300-312. DOI: 10.1097/RTI.0000000000000291. View

Yan N, Guo S, Zhang H, Zhang Z, Shen S, Li X . BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective. Front Oncol. 2022; 12:863043. PMC: 9008712. DOI: 10.3389/fonc.2022.863043. View

Le Chevalier T, Lynch T . Adjuvant treatment of lung cancer: current status and potential applications of new regimens. Lung Cancer. 2005; 46 Suppl 2:S33-9. DOI: 10.1016/s0169-5002(04)80039-4. View

Aldawsari H, Singh S, Alhakamy N, Bakhaidar R, Halwani A, Sreeharsha N . Adenosine Conjugated Docetaxel Nanoparticles-Proof of Concept Studies for Non-Small Cell Lung Cancer. Pharmaceuticals (Basel). 2022; 15(5). PMC: 9144510. DOI: 10.3390/ph15050544. View

10.

Tang B, Tian Y, Liao Y, Li Z, Yu S, Su H . CBX8 exhibits oncogenic properties and serves as a prognostic factor in hepatocellular carcinoma. Cell Death Dis. 2019; 10(2):52. PMC: 6361915. DOI: 10.1038/s41419-018-1288-0. View

11.

Wang S, Denton K, Hobbs K, Weaver T, McFarlane J, Connelly K . Optimization of Ligands Using Focused DNA-Encoded Libraries To Develop a Selective, Cell-Permeable CBX8 Chromodomain Inhibitor. ACS Chem Biol. 2019; 15(1):112-131. PMC: 7247616. DOI: 10.1021/acschembio.9b00654. View

12.

Chen A, Peng Q, Fong S, Lee K, Yeung W, Lee Y . DNA Damage Response and Cell Cycle Regulation in Pluripotent Stem Cells. Genes (Basel). 2021; 12(10). PMC: 8535646. DOI: 10.3390/genes12101548. View

13.

Zeng F, Luo L, Li D, Guo J, Guo M . KPNA2 interaction with CBX8 contributes to the development and progression of bladder cancer by mediating the PRDM1/c-FOS pathway. J Transl Med. 2021; 19(1):112. PMC: 7972191. DOI: 10.1186/s12967-021-02709-5. View

14.

Wu Y, Duan Y, Li X, Zhao R, Lan B, Zhang X . CBX8 Together with SET Facilitates Ovarian Carcinoma Growth and Metastasis by Suppressing the Transcription of SUSD2. Mol Cancer Res. 2022; 20(11):1611-1622. DOI: 10.1158/1541-7786.MCR-22-0139. View

15.

Meng Q, Li L, Wang L . High CBX8 Expression Leads to Poor Prognosis in Laryngeal Squamous Cell Carcinoma by Inducing EMT by Activating the Wnt/β-Catenin Signaling Pathway. Front Oncol. 2022; 12:881262. PMC: 9259798. DOI: 10.3389/fonc.2022.881262. View

16.

He N, Wang Y, Zhang C, Wang M, Wang Y, Zuo Q . Wnt signaling pathway regulates differentiation of chicken embryonic stem cells into spermatogonial stem cells via Wnt5a. J Cell Biochem. 2017; 119(2):1689-1701. DOI: 10.1002/jcb.26329. View

17.

Kong L, Yu Y, Guan H, Jiang L, Sun F, Li X . TGIF1 plays a carcinogenic role in esophageal squamous cell carcinoma through the Wnt/β‑catenin and Akt/mTOR signaling pathways. Int J Mol Med. 2021; 47(5). PMC: 7951946. DOI: 10.3892/ijmm.2021.4910. View

18.

Zhao X, Ma L, Dai L, Zuo D, Li X, Zhu H . TNF‑α promotes the malignant transformation of intestinal stem cells through the NF‑κB and Wnt/β‑catenin signaling pathways. Oncol Rep. 2020; 44(2):577-588. PMC: 7336517. DOI: 10.3892/or.2020.7631. View

19.

Jiang L, Li J, Zhang C, Shang Y, Lin J . YAP‑mediated crosstalk between the Wnt and Hippo signaling pathways (Review). Mol Med Rep. 2020; 22(5):4101-4106. DOI: 10.3892/mmr.2020.11529. View

20.

Robinson K, Narasipura S, Wallace J, Ritz E, Al-Harthi L . β-Catenin and TCFs/LEF signaling discordantly regulate IL-6 expression in astrocytes. Cell Commun Signal. 2020; 18(1):93. PMC: 7296971. DOI: 10.1186/s12964-020-00565-2. View